Skip to main content

Medical Treatment Including Kampo Medicine

  • Chapter
  • First Online:
  • 489 Accesses

Abstract

The surgeons should perform careful assessment and diagnostic plan and are able to improve the quality of life of the patients with HD who are not doing well after operations. In assessing the soiling postoperative patient with HD, it is important to discuss whether the colon of the patient is spastic or dilated. Examination under anesthesia to determine the integrity of the anal canal and status of the sphincters is important and adjusts the patient’s expectations concerning long-term functional result and helps determine what kinds of medical treatment including enema are administrated. In case of anal canal and sphincters intact with hypomotility (atonic constipation), it is necessary to administrate laxatives including prokinetics and Kampo medicine (Juncho-to, Daiokanzo-to, Choi-joki-to containing powdered Rhubarb) for constipation in addition to probiotics. In another case of anal canal and sphincters intact with hypermotility (spastic frequent loose stool), it is suitable to administrate calcium polycarbophil and Kampo medicine Shokentyu-to including Paeoniae radix, in addition to probiotics. Successful management depends on the appropriate evaluation and medical treatment and leads to clean and dry around the neo-anorectal lesion.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Swenson O, Bill AH. Resection of the rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon. Surgery. 1948;24:212–20.

    CAS  PubMed  Google Scholar 

  2. Soave F. A new surgical technique for treatment of Hirschsprung’s disease. Surgery. 1964;56:1007–14.

    CAS  PubMed  Google Scholar 

  3. Duhamel B. A new operation for the treatment of Hirschsprung’s disease. Arch Dis Child. 1960;35:38–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rehbein F, Von Zimmermann H. Results with abdominal resection in Hirschsprung’s disease. Arch Dis Child. 1960;35:29–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. So HB, Schwartz DL, Becker JM, Daum F, Schneider KM. Endorectal “pull-through” without preliminary colostomy in neonates with Hirschsprung’s disease. J Pediatr Surg. 1980;15:470–1.

    Article  CAS  PubMed  Google Scholar 

  6. De la Torre-Mondragón L, Ortega-Salgado JA. Transanal endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 1998;33:1283–6.

    Article  PubMed  Google Scholar 

  7. Langer JC, Durrant AC, de la Torre L, Teitelbaum DH, Minkes RK, Caty MG, Wildhaber BE, Ortega SJ, Hirose S, Albanese CT. One-stage transanal Soave pullthrough for Hirschsprung disease: A multicenter experience with 141 children. Ann Surg. 2003;238:569–83.

    PubMed  PubMed Central  Google Scholar 

  8. Yanchar NL, Soucy P. Long-term outcome after Hirschsprung’s disease: Patients’ perspectives. J Pediatr Surg. 1999;34:1152–60.

    Article  CAS  PubMed  Google Scholar 

  9. Engum SA, Grosfeld JL. Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg. 2004;13:273–85.

    Article  PubMed  Google Scholar 

  10. Rintala RJ, Pakarinen MP. Outcome of anorectal malformations and Hirschsprung’s disease beyond childhood. Semin Pediatr Surg. 2010;19:160–7.

    Article  PubMed  Google Scholar 

  11. Levitt MA, Dickie B, Peña A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg. 2010;19:146–53.

    Article  PubMed  Google Scholar 

  12. Levitt MA, Peña A. Update on pediatric faecal incontinence. Eur J Pediatr Surg. 2009;19:1–9.

    Article  CAS  PubMed  Google Scholar 

  13. Levitt MA, Peña A. Pediatric fecal incontinence: A surgeon’s perspective. Pediatr Rev. 2010;31:91–101.

    Article  PubMed  Google Scholar 

  14. Levitt MA, Dickie B, Peña A. The Hirschsprungs patient who is soiling after what was considered a “successful” pull-through. Semin Pediatr Surg. 2012;21:344–53.

    Article  PubMed  Google Scholar 

  15. Bischoff A, Levitt MA, Bauer C, et al. Treatment of fecal incontinence with a comprehensive bowel management program. J Pediatr Surg. 2009;44:1278–84.

    Article  PubMed  Google Scholar 

  16. Levitt MA, Martin CA, Olesevich M, Bauer CL, Jackson LE, Peña A. Hirschsprung disease and fecal incontinence: Diagnostic and management strategies. J Pediatr Surg. 2009;44:271–7.

    Article  PubMed  Google Scholar 

  17. Peña A, Elicevik M, Levitt MA. Reoperations in Hirschsprung disease. J Pediatr Surg. 2007;42:1008–14.

    Article  PubMed  Google Scholar 

  18. Hashizume N, Yagi M, Ushijima K, Seki Y, Fukahori S, Muto M, Matsufuji H, Taguchi T. Pharmacotherapy for pediatric chronic intestinal pseudo-obstruction: Nationwide survey in Japan. Pediatr Int. 2017;59:467–72.

    Article  PubMed  Google Scholar 

  19. Hoy SM, Scott LJ, Wagstaff AJ. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69:123–36.

    Article  CAS  PubMed  Google Scholar 

  20. Ohkubo H, Iida H, Takahashi H, Yamada E, Sakai E, Higurashi T, Sekino Y, Endo H, Sakamoto Y, Inamori M, Sato H, Fujimoto K, Nakajima A. An epidemiologic survey of chronic intestinal pseudo-obstruction and evaluation of the newly proposed diagnostic criteria. Digestion. 2012;86:12–9.

    Article  PubMed  Google Scholar 

  21. Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudoobstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition J Pediatr Gastroenterol Nutr. 1988;7:323–32.

    CAS  PubMed  Google Scholar 

  22. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther. 1996;10:403–9.

    Article  CAS  PubMed  Google Scholar 

  23. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989;96:704–12.

    CAS  PubMed  Google Scholar 

  24. Hiyama T, Yoshihara M, Matsuo K, Kusunoki H, Kamada T, Ito M, Tanaka S, Chayama K, Haruma K. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2007;22:1566–70.

    Article  PubMed  Google Scholar 

  25. Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Phys. 1989;257:470–4.

    Article  Google Scholar 

  26. Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004;19:687–94.

    Article  CAS  PubMed  Google Scholar 

  27. Akamaru Y, Takahashi T, Nishida T, Omori T, Nishikawa K, Mikata S, Yamamura N, Miyazaki S, Noro H, Takiguchi S, Mori M, Doki Y. Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial. J Gastrointest Surg. 2015;19:467–72.

    Article  PubMed  Google Scholar 

  28. Katsuno H, Maeda K, Kaiho T, Kunieda K, Funahashi K, Sakamoto J, Kono T, Hasegawa H, Furukawa Y, Imazu Y. Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo controlled study (JFMC39-0902). Jpn J Clin Oncol. 2015;45:650–6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Uehara S, Ogawa K, Arimitsu J, Okuyama H. “Ninjinto” (ginseng decoction), a traditional Japanese herbal medicine, improves gastrointestinal symptoms and immune competence in patients with chronic intestinal failure. Evid Based Complement Alternat Med. 2015;2015:462586.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Tokita Y, Yuzurihara M, Sakaguchi M, Satoh K, Kase Y. The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci. 2007;104:303–10.

    Article  CAS  PubMed  Google Scholar 

  31. Shibata C, Sasaki I, Naito H, Ueno T, Matsuno S. The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs. Surgery. 1999;126:918–24.

    Article  CAS  PubMed  Google Scholar 

  32. Fukuda H, Chen C, Mantyh C, Ludwig K, Pappas TN, Takahashi T. The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats. J Surg Res. 2006;131:290–5.

    Article  PubMed  Google Scholar 

  33. Iwai N, Kume Y, Kimura O, Ono S, Aoi S, Tsuda T. Effects of herbal medicine Dai-Kenchu-to on anorectal function in children with severe constipation. Eur J Pediatr Surg. 2007;17:115–8.

    Article  CAS  PubMed  Google Scholar 

  34. Takagi A, Yagi M, Tanaka Y, Asagiri K, Asakawa T, Tanaka H, Ishii S, Egami H, Akaiwa M, Tsuru T. The herbal medicine daikenchuto ameliorates an impaired anorectal motor activity in postoperative pediatric patients with an anorectal malformation: a pilot study. Int Surg. 2010;95:350–5.

    PubMed  Google Scholar 

  35. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–78.

    Article  CAS  PubMed  Google Scholar 

  36. Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, Joly F, Kelly D, Lal S, Staun M, Szczepanek K, Van Gossum A, Wanten G, Schneider SM. Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN: ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247–307.

    Article  PubMed  Google Scholar 

  37. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int. 2007;49:485–90.

    Article  PubMed  Google Scholar 

  38. Korterink JJ, Ockeloen L, Benninga MA, Tabbers MM, Hilbink M, Deckers-Kocken JM. Probiotics for childhood functional gastrointestinal disorders: A systematic review and meta-analysis. Acta Paediatr. 2014;103:365–72.

    Article  PubMed  Google Scholar 

  39. Tabbers MM, Benninga MA. Constipation in children: fibre and probiotics. BMJ Clin Evid. 2015;2015:0303.

    PubMed  PubMed Central  Google Scholar 

  40. Kanamori Y, Kitano Y, Hashizume K, Sugiyama M, Tomonaga T, Takayasu H, Egami S, Goishi K, Shibuya K, Kawana Y, Marumo G, Kikuchi A, Kozuma S, Taketani Y, Sekiyama Y. A case of laryngeal atresia (congenital high airway obstruction syndrome) with chromosome 5p deletion syndrome rescued by ex utero intrapartum treatment. J Pediatr Surg. 2004;39:E25–8.

    Article  PubMed  Google Scholar 

  41. Wang X, Li Z, Xu Z, Wang Z, Feng J. Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Color Dis. 2015;30:105–10.

    Article  Google Scholar 

  42. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol. 2015;21:3072–84.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Chiba T, Kudara N, Sato M, Chishima R, Abiko Y, Inomata M, Orii S, Suzuki K. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil. Hepato-Gastroenterology. 2005;52:1416–20.

    PubMed  Google Scholar 

  44. Catto-Smith AG, Coffey CM, Nolan TM, et al. Fecal incontinence after the surgical treatment of Hirschsprung disease. J Pediatr. 1995;127:954–7.

    Article  CAS  PubMed  Google Scholar 

  45. Teitelbaum DH, Drongowski RA, Chamberlain JN, Coran AG. Long-term stooling patterns in infants undergoing primary endorectal pullthrough for Hirschsprung’s disease. J Pediatr Surg. 1997;32:1049–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minoru Yagi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yagi, M., Fukahori, S. (2019). Medical Treatment Including Kampo Medicine. In: Taguchi, T., Matsufuji, H., Ieiri, S. (eds) Hirschsprung’s Disease and the Allied Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-3606-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3606-5_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3605-8

  • Online ISBN: 978-981-13-3606-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics